share_log

BioCryst Pharmaceuticals(BCRX.US) Director Buys US$31,900 in Common Stock

moomoo News ·  May 22 08:07

$BioCryst Pharmaceuticals (BCRX.US)$ Director Hutson Nancy J purchased 5,000 shares of common stock on May 20, 2024 at an average price of $6.38 for a total value of $31,900.

1716379650099794126.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment